TeleOPT: Telehealth Physical Therapy for Chronic Back Pain - Ancillary Study to NCT03859713

Sponsor
University of Utah (Other)
Overall Status
Completed
CT.gov ID
NCT05103462
Collaborator
Intermountain Health Care, Inc. (Other), Johns Hopkins University (Other)
126
2
1
11.8
63
5.3

Study Details

Study Description

Brief Summary

This study evaluated the feasibility of an 8-week physical therapy program for persons with chronic low back pain provided entirely using telehealth with real-time, interactive video sessions with a physical therapist.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Telehealth Physical Therapy
N/A

Detailed Description

At the time of the onset of the COVID pandemic, the research team was conducting a clinical trial (the OPTIMIZE trial) investigating different nonpharmacologic treatments for persons with chronic low back pain (NCT03859713). One intervention arm in this trial is in-person physical therapy. COVID-related restrictions on in-person care prompted suspension of the OPTIMIZE trial. In order to accommodate persons in the midst of receiving treatment at the time of suspension, the study team adapted the in-person protocol for physical therapy for telehealth delivery using two-way, real-time video sessions. Because of the lack of research examining the feasibility of telehealth physical therapy provided in this manner, the study team decided to conduct a pilot study to examine the feasibility of the telehealth protocol.

This study was a prospective, longitudinal cohort of persons with chronic LBP seeking care in one of three healthcare systems; University of Utah Health and Intermountain Healthcare in Salt Lake City, Utah, and Johns Hopkins Medicine in Baltimore, Maryland. All participants were offered up to 8 weekly sessions of telehealth physical therapy. Outcomes included measures of acceptability, appropriateness, feasibility and fidelity as well as effectiveness measures including the Oswestry Disability Index and the PROMIS-29 health domains. Assessments occurred at baseline and after 10- and 26-weeks.

Study Design

Study Type:
Interventional
Actual Enrollment :
126 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Prospective, longitudinal cohort designProspective, longitudinal cohort design
Masking:
None (Open Label)
Masking Description:
The study has only one arm
Primary Purpose:
Treatment
Official Title:
Observational Study of Telehealth Physical Therapy Provided for Persons With Chronic Low Back Pain
Actual Study Start Date :
Aug 18, 2020
Actual Primary Completion Date :
Dec 18, 2020
Actual Study Completion Date :
Aug 13, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Telehealth Physical Therapy

Weekly sessions of education, advice and exercise instruction provided by a licensed physical therapist using real-time, interactive video conferencing platform.

Behavioral: Telehealth Physical Therapy
Weekly sessions of physical therapy provided using two-way, interactive, video technology consisting of education, advice and exercise instruction.

Outcome Measures

Primary Outcome Measures

  1. Participant Satisfaction with Telehealth Treatment [10-weeks]

    Survey of participants evaluating treatment satisfaction

  2. Rate of refusal to participate [Baseline]

    Ratio of persons entering the study among all those eligibility for enrollment

  3. Rate of enrolled participants initiating telehealth treatment [10-weeks]

    Ratio of persons attending at least 1 treatment session among all those enrolled

  4. Number of sessions [10-weeks]

    Number of telehealth physical therapy sessions attended

  5. Change in Oswestry from baseline to 10-weeks [baseline, 10 weeks]

    10 item measure of back pain-related disability

  6. Change in Oswestry from baseline to 26-weeks [baseline, 26 weeks]

    10 item measure of back pain-related disability

  7. Change in Pain Interference from baseline to 10 weeks [baseline, 10 weeks]

    PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10

  8. Change in Pain Interference from baseline to 26 weeks [baseline, 26 weeks]

    PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10

  9. Change in Pain Intensity from baseline to 10 weeks [baseline, 10 weeks]

    PROMIS single item (part of PROMIS-29) assessing pain intensity on 0-10 rating scale

  10. Change in Pain Intensity from baseline to 26 weeks [baseline, 26 weeks]

    PROMIS single item (part of PROMIS-29) assessing pain intensity on 0-10 rating scale

  11. Change in Fatigue from baseline to 10 weeks [baseline, 10 weeks]

    PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10

  12. Change in Fatigue from baseline to 26 weeks [baseline, 26 weeks]

    PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10

  13. Change in Sleep Disturbance from baseline to 10 weeks [baseline, 10 weeks]

    PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10

  14. Change in Sleep Disturbance from baseline to 26 weeks [baseline, 26 weeks]

    PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10

  15. Change in Anxiety from baseline to 10 weeks [baseline, 10 weeks]

    PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10

  16. Change in Anxiety from baseline to 26 weeks [baseline, 26 weeks]

    PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10

  17. Change in Depression from baseline to 10 weeks [baseline, 10 weeks]

    PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10

  18. Change in Depression from baseline to 26 weeks [baseline, 26 weeks]

    PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10

  19. Change in Social Role Participation from baseline to 10 weeks [baseline, 10 weeks]

    PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10

  20. Change in Social Role Participation from baseline to 26 weeks [baseline, 26 weeks]

    PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10

  21. Change in Physical Function from baseline to 10 weeks [baseline, 10 weeks]

    PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10

  22. Change in Physical Function from baseline to 26 weeks [baseline, 26 weeks]

    PROMIS 4-item short form (part of PROMIS-29) assessed as a T-score with mean = 50 and SD = 10

  23. Change in Pain Self-Efficacy Scale from baseline to 10 weeks [baseline, 10 weeks]

    10-item measure of confidence in performing activities even with pain

  24. Change in Pain Self-Efficacy Scale from baseline to 26 weeks [baseline, 26 weeks]

    10-item measure of confidence in performing activities even with pain

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 64 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18 - 64 years at the time of enrollment.

  • Meets NIH Task Force definition of chronic LBP based on two questions: 1) How long has LBP has been an ongoing problem for you? and 2) How often has LBP been an ongoing problem for you over the past 6 months? A response of greater than 3 months to question 1, and "at least half the days in the past 6 months" to question 2 is required to satisfy the NIH definition of chronic LBP.

  • Healthcare visit for LBP in the past 90 days.

  • At least moderate levels of pain and disability requiring ODI score >24 and pain intensity rating > 4.

Exclusion Criteria:
  • Evidence of serious pathology as a cause of LBP including neoplasm, inflammatory disease (e.g., ankylosing spondylitis), vertebral osteomyelitis, etc.

  • Evidence of a specific spinal pathology as the cause of LBP including spine fracture, spinal stenosis, radiculopathy, etc.

  • Knowingly pregnant

  • Unable to participate in telehealth due to lack of technology or internet access

  • Has received physical therapy for LBP in prior 90 days

  • Currently receiving substance use disorder treatment

  • Any lumbar spine surgery in the past year.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Johns Hopkins University Baltimore Maryland United States 21287
2 Intermountain Health Care Salt Lake City Utah United States 84107

Sponsors and Collaborators

  • University of Utah
  • Intermountain Health Care, Inc.
  • Johns Hopkins University

Investigators

  • Principal Investigator: Julie Fritz, PT, PhD, University of Utah

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Julie Fritz, Distinguished Professor, University of Utah
ClinicalTrials.gov Identifier:
NCT05103462
Other Study ID Numbers:
  • IRB_00116150
First Posted:
Nov 2, 2021
Last Update Posted:
Nov 2, 2021
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Julie Fritz, Distinguished Professor, University of Utah
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 2, 2021